270 related articles for article (PubMed ID: 9506452)
1. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers--correlations to healing status.
Wallace HJ; Stacey MC
J Invest Dermatol; 1998 Mar; 110(3):292-6. PubMed ID: 9506452
[TBL] [Abstract][Full Text] [Related]
2. Etanercept decreases tumor necrosis factor-alpha activity in chronic wound fluid.
Cowin AJ; Hatzirodos N; Rigden J; Fitridge R; Belford DA
Wound Repair Regen; 2006; 14(4):421-6. PubMed ID: 16939569
[TBL] [Abstract][Full Text] [Related]
3. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling.
Trøstrup H; Lundquist R; Christensen LH; Jorgensen LN; Karlsmark T; Haab BB; Agren MS
Br J Dermatol; 2011 Aug; 165(2):292-301. PubMed ID: 21517798
[TBL] [Abstract][Full Text] [Related]
4. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers.
Cowin AJ; Hatzirodos N; Holding CA; Dunaiski V; Harries RH; Rayner TE; Fitridge R; Cooter RD; Schultz GS; Belford DA
J Invest Dermatol; 2001 Nov; 117(5):1282-9. PubMed ID: 11710945
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alfa in nonhealing venous leg ulcers.
Charles CA; Romanelli P; Martinez ZB; Ma F; Roberts B; Kirsner RS
J Am Acad Dermatol; 2009 Jun; 60(6):951-5. PubMed ID: 19344978
[TBL] [Abstract][Full Text] [Related]
6. Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers.
Drinkwater SL; Burnand KG; Ding R; Smith A
J Vasc Surg; 2003 Nov; 38(5):1106-12. PubMed ID: 14603223
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.
Senet P; Bon FX; Benbunan M; Bussel A; Traineau R; Calvo F; Dubertret L; Dosquet C
J Vasc Surg; 2003 Dec; 38(6):1342-8. PubMed ID: 14681639
[TBL] [Abstract][Full Text] [Related]
8. The relationship between cytokine concentrations and wound healing in chronic venous ulceration.
Gohel MS; Windhaber RA; Tarlton JF; Whyman MR; Poskitt KR
J Vasc Surg; 2008 Nov; 48(5):1272-7. PubMed ID: 18771884
[TBL] [Abstract][Full Text] [Related]
9. A reduction in serum cytokine levels parallels healing of venous ulcers in patients undergoing compression therapy.
Murphy MA; Joyce WP; Condron C; Bouchier-Hayes D
Eur J Vasc Endovasc Surg; 2002 Apr; 23(4):349-52. PubMed ID: 11991698
[TBL] [Abstract][Full Text] [Related]
10. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
Nwomeh BC; Liang HX; Cohen IK; Yager DR
J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers.
Trengove NJ; Bielefeldt-Ohmann H; Stacey MC
Wound Repair Regen; 2000; 8(1):13-25. PubMed ID: 10760211
[TBL] [Abstract][Full Text] [Related]
12. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
13. Iron and 8-isoprostane levels in acute and chronic wounds.
Yeoh-Ellerton S; Stacey MC
J Invest Dermatol; 2003 Oct; 121(4):918-25. PubMed ID: 14632213
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and growth factors in keratinocytes and sweat glands in chronic venous leg ulcers. An immunohistochemical study.
Tian YW; Stacey MC
Wound Repair Regen; 2003; 11(5):316-25. PubMed ID: 12950634
[TBL] [Abstract][Full Text] [Related]
15. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
16. Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis.
Armstrong L; Foley NM; Millar AB
Thorax; 1999 Jun; 54(6):524-30. PubMed ID: 10335007
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of wound fluid biomarkers to determine healing in adults with venous leg ulcers: A prospective study.
Stacey MC; Phillips SA; Farrokhyar F; Swaine JM
Wound Repair Regen; 2019 Sep; 27(5):509-518. PubMed ID: 31020747
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers.
Harris IR; Yee KC; Walters CE; Cunliffe WJ; Kearney JN; Wood EJ; Ingham E
Exp Dermatol; 1995 Dec; 4(6):342-9. PubMed ID: 8608341
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
20. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin.
Serra R; Buffone G; Falcone D; Molinari V; Scaramuzzino M; Gallelli L; de Franciscis S
Wound Repair Regen; 2013; 21(3):395-401. PubMed ID: 23531093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
